Page last updated: 2024-10-31

nabumetone and Bullous Dermatoses

nabumetone has been researched along with Bullous Dermatoses in 1 studies

Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.

Research Excerpts

ExcerptRelevanceReference
"Pseudoporphyria cutanea tarda is a well described bullous skin disorder which resembles porphyria cutanea tarda."1.42[Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria]. ( Bygum, A; Velander, MJ; Þorsteinsdóttir, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Þorsteinsdóttir, S1
Velander, MJ1
Bygum, A1

Other Studies

1 other study available for nabumetone and Bullous Dermatoses

ArticleYear
[Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
    Ugeskrift for laeger, 2015, Apr-20, Volume: 177, Issue:17

    Topics: Adult; Butanones; Female; Furosemide; Humans; Male; Middle Aged; Nabumetone; Porphyria Cutanea Tarda

2015